Jennifer A. Doudna, Ph.D.

Synthego is one of the most promising and necessary companies to emerge in the field of genome engineering. By increasing access to this scientific advancement, Synthego will have an immediate impact on life sciences researchers and is poised to transform the industry by making the application of CRISPR simpler, faster, and more valuable to innovators previously unable to realize its full potential.